Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update Life Science Investing
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2026 Life Science Investing
HCW Biologics Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum Life Science Investing
Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor Life Science Investing
Acadia Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, Following a Distinguished Career Life Science Investing
Century Therapeutics Selected for Oral Presentation of CNTY?813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions Life Science Investing
Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection Life Science Investing
Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich's Ataxia Life Science Investing
